Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Assay Kit

HMPV N/Nucleoprotein ELISA Kit

Catalog #:   KVV30001 Specific References (50) DATASHEET
Sample type: Plasma, Serum
Sensitivity: 0.65 ng/mL
Range: 1.56 - 100 ng/mL
Overview

Catalog No.

KVV30001

Specificity

HMPV N/Nucleoprotein

Detection method

Colorimetric

Sample type

Plasma, Serum

Assay type

Quantitative

Range

1.56 - 100 ng/mL

Sensitivity

0.65 ng/mL

Precision

CV<15%

Recovery

80-120%

Shipping

2-8 ℃

Stability and Storage

The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.

Data Image
References

Impact of SARS-CoV-2 P.1 Variant Infection on the Nasopharyngeal Commensal Bacterial Microbiome of Individuals from the Brazilian Amazon., PMID:40431261

Prevalence of Viral and Bacterial Co-Infections in SARS-CoV-2-Positive Individuals in Cyprus 2020-2022., PMID:40427063

Screening bacterial effectors and human virus proteins in yeast to identify host factors driving tombusvirus RNA recombination: a role for autophagy and membrane phospholipid content., PMID:40422074

Genomic Epidemiology of Healthcare-Associated Respiratory Virus Infections., PMID:40313286

Development of Standard and Rapid Antigen Detection Assays for Human Metapneumovirus., PMID:40297986

Human Metapneumovirus: Emergence, Impact, and Public Health Significance., PMID:40255736

Increased risk during winter: common respiratory viruses and clinical outcomes in hospitalized children., PMID:40253326

A Randomized Phase 1 Clinical Trial of a Respiratory Syncytial Virus and Human Metapneumovirus Combination Protein-Based Virus-like Particle Vaccine in Adults 60-75 Years of Age., PMID:40201719

The global burden of human metapneumovirus-associated acute respiratory infections in older adults: a systematic review and meta-analysis., PMID:39954700

Human Metapneumovirus: an emerging respiratory pathogen and the urgent need for improved Diagnostics, surveillance, and vaccine development., PMID:39862211

Changes in infant respiratory pathogens pre-, during, and post-COVID-19 non-pharmacological interventions in Beijing., PMID:39844210

Respiratory Syncytial Virus and Other Respiratory Viruses in Hospitalized Infants During the 2023-2024 Winter Season in Mexico., PMID:39772224

Analysis of respiratory pathogen detection in hospitalized children with acute respiratory tract infections after ending the zero COVID policy., PMID:39738485

Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus., PMID:39550381

Demographics, Clinical Presentation and Outcome of Metapneumovirus Infection in Adults: A Case Series Analysis at Scarborough General Hospital, United Kingdom., PMID:39524165

The Distribution of Respiratory Viral Pathogens Among the Symptomatic Respiratory Tract Infection Patients From Dhaka City in the Pre-COVID-19 Pandemic Era., PMID:39493125

Human metapneumovirus SH protein promotes JAK1 degradation to impair host IL-6 signaling., PMID:39412256

Exploring Chemical Space to Identify Partial Binders Against hMPV Nucleocapsid Protein., PMID:39286955

Molecular detection and genotyping of HMPV in patients with severe acute respiratory infection in India., PMID:39221771

Rapid and one-tube detection of human metapneumovirus using the RT-RPA and CRISPR/Cas12a., PMID:39038660

Safety and Immunogenicity of an mRNA-Based hMPV/PIV3 Combination Vaccine in Seropositive Children., PMID:38738290

Novel insights into the host cell glycan binding profile of human metapneumovirus., PMID:38690874

Predictors of Respiratory Syncytial Virus, Influenza Virus, and Human Metapneumovirus Carriage in Children Under 5 Years With WHO-Defined Fast-Breathing Pneumonia in Pakistan., PMID:38616564

Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic, Germany, 2021 to 2023., PMID:38551098

IFN-λ drives distinct lung immune landscape changes and antiviral responses in human metapneumovirus infection., PMID:38530032

Surge of lower respiratory tract group A streptococcal infections in England in winter 2022: epidemiology and clinical profile., PMID:37997140

Structure of the N-RNA/P interface indicates mode of L/P recruitment to the nucleocapsid of human metapneumovirus., PMID:37993464

Interactions among acute respiratory viruses in Beijing, Chongqing, Guangzhou, and Shanghai, China, 2009-2019., PMID:37964991

Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirus., PMID:37738240

A decade of human metapneumovirus in hospitalized children with acute respiratory infection: molecular epidemiology in central Vietnam, 2007-2017., PMID:37735242

Structural basis for respiratory syncytial virus and human metapneumovirus neutralization., PMID:37544710

Paradigm shift of respiratory viruses causing lower respiratory tract infection in children during COVID-19 pandemic in India., PMID:37515805

Conserved allosteric inhibitory site on the respiratory syncytial virus and human metapneumovirus RNA-dependent RNA polymerases., PMID:37337079

Human Metapneumovirus Reinfection in Aged Mice Recapitulates Increased Disease Severity in Elderly Humans Infected with Human Metapneumovirus., PMID:37261717

Specific Residues in the C-Terminal Domain of the Human Metapneumovirus Phosphoprotein Are Indispensable for Formation of Viral Replication Centers and Regulation of the Function of the Viral Polymerase Complex., PMID:37092993

Human Metapneumovirus (hMPV) Infection and MPV467 Treatment in Immunocompromised Cotton Rats Sigmodon hispidus., PMID:36851691

The Contribution of Viruses and Bacteria to Childhood Community-acquired Pneumonia: 11-Year Observational Study From Norway., PMID:36795570

Cross-protective antibodies against common endemic respiratory viruses., PMID:36781872

Bronchiolitis Due to RSV and HMPV-Epidemiology, Clinical Course, and Prognosis: Experience of a Single Tertiary Center., PMID:36744682

Emergence and Potential Extinction of Genetic Lineages of Human Metapneumovirus between 2005 and 2021., PMID:36507832

The emergence of human metapneumovirus G gene duplication in hospitalized patients with respiratory tract infection, India, 2016-2018., PMID:36399244

Characterization of prefusion-F-specific antibodies elicited by natural infection with human metapneumovirus., PMID:36130517

Clinical significance and role of coinfections with respiratory pathogens among individuals with confirmed severe acute respiratory syndrome coronavirus-2 infection., PMID:36117597

Human metapneumovirus M2-2 protein inhibits RIG-I signaling by preventing TRIM25-mediated RIG-I ubiquitination., PMID:36045682

A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein., PMID:36003370

Respiratory syncytial virus among children hospitalized with severe acute respiratory infection in Kashmir, a temperate region in northern India., PMID:35976005

Pediatric burden and seasonality of human metapneumovirus over 5 years in Managua, Nicaragua., PMID:35965382

Role of human metapneumovirus glycoprotein G in modulation of immune responses., PMID:35958551

Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein., PMID:35944529

Detection of Respiratory Viruses in SARS-CoV-2-Negative Specimens from January to March 2020 in Fukuoka, Japan., PMID:35908870

Datasheet
$ 1128
Product specifications
96 T 1128

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

HMPV N/Nucleoprotein ELISA Kit [KVV30001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only